Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reza Asari

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Gastrointestinal Endoscopy|April 26, 2016
A retrospective study on the safety, diagnostic yield, and therapeutic effects of endoscopic unroofing for small gastric subepithelial tumorsWerner Dolak, Andrea Beer, Ivan Kristo, et al.
Anticancer Research|March 14, 2013
Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for gastroesophageal adenocarcinomaUrsula Pluschnig, Sebastian F Schoppmann, Matthias Preusser, et al.
Langenbeck'S Archives of Surgery|September 6, 2023
Platelets as a prognostic factor for patients with adenocarcinoma of the gastroesophageal junctionJoy Feka, Gerd Jomrich, Daniel Winkler, et al.
Langenbeck'S Archives of Surgery|June 6, 2023
Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapyLisa Gensthaler, Gerd Jomrich, Jonas Brugger, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 15, 2020
Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidityMatthias Paireder, Gerd Jomrich, Ivan Kristo, et al.
Anticancer Research|May 7, 2013
The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume centerKatrin Schwameis, Ahmed Ba-Ssalamah, Fritz Wrba, et al.
Oncotarget|February 23, 2018
The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junctionGerd Jomrich, Marlene Hollenstein, Maximilian John, et al.
Journal of Cancer Research and Clinical Oncology|October 14, 2024
Elevated fibrinogen-albumin ratio is an adverse prognostic factor for patients with primarily resected gastroesophageal adenocarcinomaGerd Jomrich, Winny Yan, Dagmar Kollmann, et al.
Molecular and Clinical Oncology|March 21, 2014
Lack of correlation between blood group and HER-2 status in adenocarcinomas of the upper gastrointestinal tractMichael Hejna, Peter Birner, Matthias Preusser, et al.
Cancers|November 9, 2024
Overexpression of Fibroblast Growth Factor 8 Is a Predictor of Impaired Survival in Esophageal Squamous Cell Carcinoma and Correlates with ALK/EML4 AlterationGerd Jomrich, Dagmar Kollmann, Winny Yan, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Gastrointestinal Endoscopy|April 26, 2016
A retrospective study on the safety, diagnostic yield, and therapeutic effects of endoscopic unroofing for small gastric subepithelial tumorsWerner Dolak, Andrea Beer, Ivan Kristo, et al.
Anticancer Research|March 14, 2013
Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for gastroesophageal adenocarcinomaUrsula Pluschnig, Sebastian F Schoppmann, Matthias Preusser, et al.
Langenbeck'S Archives of Surgery|September 6, 2023
Platelets as a prognostic factor for patients with adenocarcinoma of the gastroesophageal junctionJoy Feka, Gerd Jomrich, Daniel Winkler, et al.
Langenbeck'S Archives of Surgery|June 6, 2023
Preoperative BChE serves as a prognostic marker in patients with resectable AEG after neoadjuvant chemotherapyLisa Gensthaler, Gerd Jomrich, Jonas Brugger, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 15, 2020
Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidityMatthias Paireder, Gerd Jomrich, Ivan Kristo, et al.
Anticancer Research|May 7, 2013
The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume centerKatrin Schwameis, Ahmed Ba-Ssalamah, Fritz Wrba, et al.
Oncotarget|February 23, 2018
The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junctionGerd Jomrich, Marlene Hollenstein, Maximilian John, et al.
Journal of Cancer Research and Clinical Oncology|October 14, 2024
Elevated fibrinogen-albumin ratio is an adverse prognostic factor for patients with primarily resected gastroesophageal adenocarcinomaGerd Jomrich, Winny Yan, Dagmar Kollmann, et al.
Molecular and Clinical Oncology|March 21, 2014
Lack of correlation between blood group and HER-2 status in adenocarcinomas of the upper gastrointestinal tractMichael Hejna, Peter Birner, Matthias Preusser, et al.
Cancers|November 9, 2024
Overexpression of Fibroblast Growth Factor 8 Is a Predictor of Impaired Survival in Esophageal Squamous Cell Carcinoma and Correlates with ALK/EML4 AlterationGerd Jomrich, Dagmar Kollmann, Winny Yan, et al.
Pageof 7